Showing 1 - 9 results of 9 for search 'E. Jason Abel', query time: 0.04s Refine Results
  1. 1
    Management of Locally Advanced Renal Cell Carcinoma

    Management of Locally Advanced Renal Cell Carcinoma by Vsevolod B. Matveev, Sarah P. Psutka, Grant D. Stewart, Gennady Bratslavsky, E. Jason Abel

    Published 2022-11-01
    Get full text
    Article
  2. 2
    The SUMO protease SENP1 promotes aggressive behaviors of high HIF2α expressing renal cell carcinoma cells

    The SUMO protease SENP1 promotes aggressive behaviors of high HIF2α expressing renal cell carcinoma cells by Moon Hee Lee, Kyung Sung, David Beebe, Wei Huang, Dan Shapiro, Shigeki Miyamoto, E. Jason Abel

    Published 2022-10-01
    Get full text
    Article
  3. 3
    Delayed Ureterectomy after Incomplete Nephroureterectomy for Upper Tract Urothelial Carcinoma: Pathologic Findings and Outcomes

    Delayed Ureterectomy after Incomplete Nephroureterectomy for Upper Tract Urothelial Carcinoma: Pathologic Findings and Outcomes by E. Jason Abel, Mark B. Fisher, Surena F. Matin, Ashish M. Kamat, Colin P. Dinney, H. Barton Grossman

    Published 2013-12-01
    Get full text
    Article
  4. 4
    Patient-specific organotypic blood vessels as an in vitro model for anti-angiogenic drug response testing in renal cell carcinomaResearch in context

    Patient-specific organotypic blood vessels as an in vitro model for anti-angiogenic drug response testing in renal cell carcinomaResearch in context by José A. Jiménez-Torres, María Virumbrales-Muñoz, Kyung E. Sung, Moon Hee Lee, E. Jason Abel, David J. Beebe

    Published 2019-04-01
    Get full text
    Article
  5. 5
    B2B: Kidney Cancer Summary

    B2B: Kidney Cancer Summary by Simon Tanguay, E. Jason Abel, Laurence Albigès, Toni Choueiri, Axel Bex, Umberto Capitanio, Maxine Tran, Alessandro Volpe, Peter Black

    Published 2021-07-01
    Get full text
    Article
  6. 6
    Management of stage 1 renal cell cancer in patients immunosuppressed for organ transplantation or autoimmune disease

    Management of stage 1 renal cell cancer in patients immunosuppressed for organ transplantation or autoimmune disease by Ali Ghasemzadeh, Eric T. Wendt, Brendan Dolan, Juliana Craig, Glenn O. Allen, E. Jason Abel, Daniel D. Shapiro, Daniel D. Shapiro

    Published 2023-12-01
    Get full text
    Article
  7. 7
    Impact of bilateral biopsy-detected prostate cancer on an active surveillance population

    Impact of bilateral biopsy-detected prostate cancer on an active surveillance population by Jonathan H. Wang, Pablo Sierra, Kyle A. Richards, E. Jason Abel, Glen O. Allen, Tracy M. Downs, David F. Jarrard

    Published 2019-04-01
    Get full text
    Article
  8. 8
    Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals

    Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals by Daniel D. Shapiro, Jose A. Karam, Logan Zemp, Viraj A. Master, Wade J. Sexton, Ali Ghasemzadeh, Benjamin N. Schmeusser, Facundo Davaro, Taylor Peak, Dattatraya Patil, Surena Matin, Philippe E. Spiess, E. Jason Abel

    Published 2023-04-01
    Get full text
    Article
  9. 9
    Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma

    Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma by Rory M. Bade, Jennifer L. Schehr, Hamid Emamekhoo, Benjamin K. Gibbs, Tamara S. Rodems, Matthew C. Mannino, Joshua A. Desotelle, Erika Heninger, Charlotte N. Stahlfeld, Jamie M. Sperger, Anupama Singh, Serena K. Wolfe, David J. Niles, Waddah Arafat, John A. Steinharter, E. Jason Abel, David J. Beebe, Xiao X. Wei, Rana R. McKay, Toni K. Choueri, Joshua M. Lang

    Published 2021-09-01
    Get full text
    Article

Search Tools: